Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 1;29(5):1378-1400.
doi: 10.1212/CON.0000000000001344.

Autoimmune Axonal Neuropathies

Jennifer A Tracy
Review

Autoimmune Axonal Neuropathies

Jennifer A Tracy. Continuum (Minneap Minn). .

Abstract

Objective: This article reviews autoimmune axonal neuropathies, their characteristic clinical features, disease and antibody associations, appropriate ancillary testing, treatment, and prognosis.

Latest developments: In 2021, the American College of Rheumatology and the Vasculitis Foundation released new summary guidelines for the treatment of antineutrophil cytoplasmic autoantibody-associated vasculitides. In addition, novel autoantibodies have been recently identified; they are often paraneoplastic and associated with axonal neuropathies.

Essential points: Recognition of autoimmune axonal neuropathies is important because of the potential for effective treatment to either reverse deficits or slow the progression of disease. It is necessary to properly assess for associations with other systemic disorders (eg, systemic vasculitis, connective tissue disease, neoplasm) so that adequate treatment for both neurologic and non-neurologic aspects of the disease can be initiated.

PubMed Disclaimer

References

    1. Wolf J, Schmitt V, Palm F, Grau AJ, Bergner R. Peripheral neuropathy as initial manifestation of primary systemic vasculitides. J Neurol 2013;260(4):1061–1070. doi:10.1007/s00415-012-6760-7 - DOI
    1. Collins MP, Dyck PJB, Gronseth GS, et al. Peripheral Nerve Society guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst JPNS 2010;15(3):176–184. doi:10.1111/j.1529-8027.2010.00281.x - DOI
    1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013;65(1):1–11. doi:10.1002/art.37715 - DOI
    1. Suppiah R, Hadden RDM, Batra R, et al. Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Rheumatol Oxf Engl 2011;50(12):2214–2222. doi:10.1093/rheumatology/ker266 - DOI
    1. Cartin-Ceba R, Peikert T, Specks U. Pathogenesis of ANCA-associated vasculitis. Curr Rheumatol Rep 2012;14(6):481–493. doi:10.1007/s11926-012-0286-y - DOI

MeSH terms

Substances

LinkOut - more resources